01 Communique Laboratory Inc. provided an update in respect of its patent litigation. On April 2, 2013 the Court entered judgment on the March 26, 2013 jury verdict finding 01's patent number 6928479 (the 479 Patent) valid but not infringed by LogMeIn. On March 26, 2013 the Jury in the trial rendered its verdict concluding that 01 Communique's 479 Patent is valid but that LogMeIn does not infringe the patent. The Company will seek to have the jury's finding of non-infringement overturned. The Company is represented by Baker & Hostetler LLP in this matter and the case was tried in the Eastern District of Virginia. As part of the patent litigation Citrix Systems Inc. (Citrix) requested an inter partes reexamination of the 479 Patent by the United States Patent and Trademark Office (USPTO), and also requested a stay in the Court proceedings which was granted by the Judge.

01 Communique Laboratory Inc. reported consolidated earnings results for the first quarter ended January 31, 2013. For the quarter, the company’s revenue was $174,475 compared to $68,088 in 2012. Loss for the period and comprehensive loss was $1,060,478 compared to $705,835 in 2012. Excluding its non-cash expenses for stock based compensation and depreciation the adjusted loss for the quarter was $875,548 compared to $419,838 in 2012 representing a $455,710 increase which is primarily a result of expenses pertaining to the LogMeIn patent lawsuit. Loss per basic and diluted share was $0.016 against $0.012 a year ago. Cash used in operating activities was $530,293 against $497,885 a year ago. Purchase of property and equipment was $5,333 against $141 a year ago.

01 Communique Laboratory Inc., Annual General Meeting, Apr 23, 2013., at 16:15 US Eastern Standard Time. Location: The Board of Trade, First Canadian Place. Agenda: To consider the financial statements of the company for the year ended October 31, 2012, together with the report of the auditors thereon; to elect directors for the ensuing year; to re-appoint auditors of the company for the ensuing year and authorize the directors to fix their remuneration; to approve certain amendments to the employee stock option plan; and to transact such other business as may properly come before the meeting.